- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery | - | RTTNews | ||
| ACLARION Aktie jetzt für 0€ handeln | |||||
| Mi | Aclarion, Inc.: First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial | 3 | GlobeNewswire (USA) | ||
| Di | Aclarion, Inc.: Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum | 1 | GlobeNewswire (USA) | ||
| 20.06. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | Aclarion, Inc.: Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
| 30.05. | Aclarion stock price target cut to $20 at Ascendiant Capital | 2 | Investing.com | ||
| 30.05. | Kursziel für Aclarion-Aktie von Ascendiant Capital auf 20 US-Dollar gesenkt | 1 | Investing.com Deutsch | ||
| 26.05. | XFRA NEW INSTRUMENTS AVAILABLE ON 26.05.2025 | 374 | Xetra Newsboard | The following instruments on XETRA do have their first trading 26.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 26.05.2025
Aktien
1 MXCFFM010000 Banco Invex S.A.
2... ► Artikel lesen | |
| 20.05. | Aclarion, Inc.: Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site | 9 | GlobeNewswire (USA) | ||
| 15.05. | Aclarion, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.05. | Aclarion, Inc.: Aclarion Announces Texas Back Institute as New CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
| 05.05. | Aclarion, Inc.: Aclarion Welcomes Advocate Health as CLARITY Trial Site | 2 | GlobeNewswire (USA) | ||
| 29.04. | Aclarion, Inc.: Aclarion Announces Commercial Agreement with Spine Institute of Louisiana | 4 | GlobeNewswire (USA) | ||
| 23.04. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.04. | Aclarion, Inc.: Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 | 2 | GlobeNewswire (USA) | ||
| 21.04. | Aclarion, Inc.: Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis | 2 | GlobeNewswire (USA) | ||
| 09.04. | Aclarion, Inc.: Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub | 1 | GlobeNewswire (USA) | ||
| 09.04. | Aclarion, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 02.04. | Aclarion, Inc.: Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California | 1 | GlobeNewswire (USA) | ||
| 28.03. | Aclarion, Inc. - 8-K, Current Report | 4 | SEC Filings |
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 457,15 | +0,16 % | Intuitive Surgical Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
| UNITEDHEALTH | 259,60 | +0,41 % | Dividendenbekanntmachungen (24.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPAGNIE DE L ODET SA FR0000062234 - 4,4 EUR DOM DEVELOPMENT SA PLDMDVL00012 7 PLN 1,6374 EUR ELBIT SYSTEMS LTD IL0010811243 0... ► Artikel lesen | |
| ROKU | 74,78 | +1,18 % | This 30-second fix made my Roku TV run like new again (and why it works) | ||
| SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,704 | -5,38 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,946 | +9,49 % | PA GOODDOCTOR (01833): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2025 | ||
| EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,002 | -50,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,208 | -3,70 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CENTENE | 46,175 | +0,91 % | Centene-Aktie läuft heute schlechter (46,0076 €) | Im Minus liegt aktuell der Anteilsschein von Centene . Die Aktie kostete zuletzt 53,62 US-Dollar. Ein Preisabschlag in Höhe von 43 Cent müssen derzeit die Aktionäre von Centene hinnehmen. Für das Papier... ► Artikel lesen | |
| CYTOSORBENTS | 0,981 | -1,70 % | Cytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR | PRINCETON, N.J., June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 0,554 | -0,90 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| QUIDELORTHO | 24,400 | +1,67 % | Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,750 | 0,00 % | VOLITIONRX LTD - 8-K, Current Report |
Das Unternehmen ACLARION INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 5,940 Euro und damit +1,02 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACLARION INC finden Sie auf Wallstreet Online.